2100 Participants Needed

Survivorship Study for Sarcoma

(CAUSAL Trial)

VS
Overseen ByVanderbilt-Ingram Services for Timely Access
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Vanderbilt-Ingram Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how having and treating sarcoma affects people over time. Participants will wear a FitBit to track activity, heart rate, and sleep, and provide samples such as blood or saliva. They will also fill out surveys and have their medical records reviewed. Anyone who has had sarcoma, regardless of current symptoms, can join. For children, their parent or caregiver and siblings aged 8 or older can also participate.

As an unphased trial, this study offers participants the opportunity to contribute to a deeper understanding of sarcoma's impact, potentially improving future care.

Do I need to stop taking my current medications for the sarcoma survivorship study?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a holistic approach to understanding sarcoma survivorship. Unlike traditional treatments that primarily focus on direct cancer therapies like surgery, chemotherapy, or radiation, this study emphasizes comprehensive lifestyle monitoring. By using FitBit devices to track physical activity, heart rate, and sleep, along with analyzing biological samples and patient surveys, researchers aim to gather valuable data on the long-term health and well-being of sarcoma survivors. This could lead to new insights on improving quality of life and managing long-term health risks for survivors.

Who Is on the Research Team?

DF

Debra Friedman, MD

Principal Investigator

Vanderbilt University/Ingram Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

I have or had sarcoma, regardless of my current disease status.
I am a pediatric patient.
I am a sibling of the patient and I am 8 years old or older.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Observational Monitoring

Participants monitor physical activity, sedentary behavior, heart rate, and sleep using a FitBit device, undergo sample collection, complete surveys, and have medical records reviewed

Approximately six years

Follow-up

Participants are monitored for long-term outcomes and effectiveness of sarcoma survivorship

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Blood Collection
  • Physical Activity Monitoring
  • Saliva Collection
  • Stool Collection
  • Surveys
  • Tissue collection
  • Urine Collection

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ObservationalExperimental Treatment7 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Vanderbilt-Ingram Cancer Center

Lead Sponsor

Trials
221
Recruited
64,400+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+